[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ono Pharmaceutical Co. Ltd.
Ono Pharmaceutical reports positive clinical trial results for ONO-2808 and ONO-4578, while also announcing an AI-driven research pact with Jorna Therapeutics, driving positive sentiment. However, the company is being deleted from the MSCI Japan Index, which may cause some concern for investors.
About Ono Pharmaceutical Co. Ltd.
Ono Pharmaceutical Co. Ltd. is a pharmaceutical company.
Price: $ #
Price 24-Hour Time-Series Raw Data
The price action is unclear due to the lack of current price data, but the positive news about the AI-driven research pact, HER2 CAR-T cell therapy, and positive clinical trial results could be seen as positive catalysts for the stock.
1-Year High: $XXXXXXXX on 2024-11-07
1-Year Low: $XXXXX on 2025-05-15
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Ono Pharmaceutical Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2024-12-12
1-Year Low: XXX on 2025-03-19
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-03-29
1-Year Low: XX on 2024-10-21
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX +31%
6 Months: XXXXXX +49%
1 Year: XXXXXX -XX%
1-Year High: XXXXX on 2025-05-12
1-Year Low: X on 2024-10-23
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XX | X |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: XXX -XXXX%
1 Year: XXX -XXXX%
1-Year High: XX on 2025-02-06
1-Year Low: X on 2024-10-20
| Social Network | X | YouTube |
|---|---|---|
| Mentions | X | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Ono Pharmaceutical Co. Ltd. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
6 Months: XXX -XXXX%
1 Year: XXX -XXXX%
1-Year High: XX on 2025-02-06
1-Year Low: X on 2024-10-20
The most influential creators that mention Ono Pharmaceutical Co. Ltd. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @TheBioNews | X | X | X | X |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-10-23
1-Year Low: XX% on 2025-07-26
Most Supportive Themes
- Positive Clinical Trial Results: (40%) Multiple posts highlight positive interim Phase II results for ONO-2808 in Multiple System Atrophy (MSA) and ONO-4578 in Gastric or Gastroesophageal Junction Cancer.
- Partnerships and Collaborations: (30%) News of Ono Pharmaceutical's AI-driven research pact with Jorna Therapeutics and deals with LigaChem Biosciences for ADC technology are positively received.
- HER2 CAR-T Cell Therapy: (20%) Mentions of FT825/ONO-8250, a HER2 CAR-T cell therapy co-developed by Fate Therapeutics and ONO PHARMACEUTICAL, in Phase X trials.
Most Critical Themes
- Index Deletion: (10%) MSCI Japan Index is deleting Ono Pharmaceutical Co. from its standard index.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | X | XX% | XX | XX% | X | X% |
| YouTube | X | XX% | X | X% | X | X% |
| Total | X | XX% | XX | XX% | X | X% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-21
1-Year Low: $XXXXXXXXXXXXXXX on 2025-02-17
Top assets mentioned In the posts about Ono Pharmaceutical Co. Ltd. in the last XX hours
Innovative Solutions & Support (ISSC)
Top topics mentioned In the posts about Ono Pharmaceutical Co. Ltd. in the last XX hours
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Ono Pharmaceutical Reports Positive Interim Phase II Results of ONO-2808 (S1P5 Agonist) in Multiple System Atrophy (MSA) Showing Signs of Efficacy #Neuroscience #DrugDevelopment #Innovation"
X Link @stellanewslife 2025-10-11T10:43Z XXX followers, XX engagements
"Ono Pharmaceutical Reports Positive Interim Phase X Results for ONO-2808 in Multiple System Atrophy (MSA) - For More Information Visit @Ono_pharma_PR #Multiple_System_Atrophy #MSA #Rare_Diseases #OrphanDrugs #Drug_Research #Ono_pharma"
X Link @CheckOrphan 2025-10-10T14:19Z 18.1K followers, XXX engagements
"ONO PHARMACEUTICAL CO. LTD. Reveals the P-II (ONO-4578-08) Trial Findings of ONO-4578 in Gastric or Gastroesophageal Junction Cancer #ono #pii #ono457808 #ono4578 #ep4antagonist #gastriccancer #gastroesophagealjunctioncancer #opdivo #clinicaltrial"
X Link @Pharmashot 2025-10-10T11:49Z 2279 followers, XX engagements
"FT825/ONO-8250 a HER2 CAR-T cell therapy co-developed by Fate Therapeutics and ONO PHARMACEUTICAL and now in Phase X trials incorporates advanced engineering techniques. The challenge in HER2 CAR-T development extends beyond merely applying CAR-T cell therapy to solid tumors; it must address the unmet medical needs associated with HER2-targeting agents like T-DXd. Key priorities include overcoming potential resistance to T-DXd and achieving higher tumor cell specificity than existing HER2-targeting drugs. At #SITC24 FT825/ONO-8250 emphasized its preferential targeting of HER2-expressing"
X Link @onco_park 2024-11-09T21:11Z 2359 followers, 2288 engagements